GC Genome plans US commercialization of pancreatic cancer test next year, "expects recovery of offering price" [Why Bio]
Predicted impact: Low
Planned US commercialization of cancer test next year; small, vague timeline.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.